Cargando…

Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry

The use of percutaneous right ventricular assist devices (pRVADs) to support patients with right ventricular (RV)-predominant cardiogenic shock (CS) refractory to optimal medical therapy is increasing progressively, and the Impella RP is the first FDA-approved pRVAD in such a clinical scenario. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botti, Giulia, Gramegna, Mario, Burzotta, Francesco, Masiero, Giulia, Briguori, Carlo, Trani, Carlo, Napodano, Massimo, Scandroglio, Anna Mara, Montorfano, Matteo, Tarantini, Giuseppe, Chieffo, Alaide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506315/ https://www.ncbi.nlm.nih.gov/pubmed/36143266 http://dx.doi.org/10.3390/jpm12091481

Ejemplares similares

Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry
por: Iannaccone, Mario, et al.
Publicado: (2023)

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Comprehensive Systematic Literature Review and Meta-Analyses
por: Ardito, Vittoria, et al.
Publicado: (2023)

A simple technique to obtain postprocedural antegrade angiographic control in single‐access Impella‐protected PCI
por: Burzotta, Francesco, et al.
Publicado: (2022)

Can we have a rationalized selection of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation in the catheterization laboratory?
por: Russo, Giulio, et al.
Publicado: (2022)

When to Achieve Complete Revascularization in Infarct-Related Cardiogenic Shock
por: Masiero, Giulia, et al.
Publicado: (2022)

Defining the optimal revascularization strategy during protected high-risk procedures with Impella
por: Sinning, Jan-Malte, et al.
Publicado: (2022)

Ischemia With No Obstructive Coronary Artery Disease: Are Misdiagnosis and Undertreatment Always Behind the Corner?
por: Ghizzoni, Giulia, et al.
Publicado: (2023)

Levelling the field of cardiovascular disease in women
por: Botti, Giulia, et al.
Publicado: (2022)

STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic
por: Alasnag, Mirvat, et al.
Publicado: (2022)

Full percutaneous biventricular support with two Impella pumps: the Bi‐Pella approach
por: Pappalardo, Federico, et al.
Publicado: (2018)

Impella RP Use in Refractory Cardiogenic Shock in a Patient Presenting With Acute Right Coronary Artery Occlusion: A Case Report
por: Abdel Jawad, Mohammad, et al.
Publicado: (2023)

Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation
por: Attisano, Tiziana, et al.
Publicado: (2020)

Impella RP as Rescue Measure for Pulmonary Embolism With Hemodynamic Compromise
por: Lashin, Hazem, et al.
Publicado: (2019)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Gender Issues in Italian Catheterization Laboratories: The Gender‐CATH Study
por: Bernelli, Chiara, et al.
Publicado: (2021)

Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction
por: Marin, Federico, et al.
Publicado: (2022)

Two cases of successful treatment of acute right heart failure with Impella RP®
por: Santer, David, et al.
Publicado: (2020)

Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery Embolization
por: Frederiksen, Peter H., et al.
Publicado: (2023)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ikhc8hci0mvf3oi4mue6p9i9e